Noninvasive Brain Stimulation in Adult Amblyopia
Midwestern University · NCT06712849
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- May 1, 2024
- Record last updated
- December 12, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this randomized controlled trial is to investigate the effectiveness of non-invasive brain stimulation in treating adults with amblyopia. The main questions it aims to answer are:
- What are the effects of non-invasive brain stimulation on neuronal plasticity in the visual cortex of adults with amblyopia, and does it produce lasting changes?
- Do cumulative sessions of non-invasive brain stimulation influence neural plasticity and higher-order visual functions in adults with amblyopia?
The investigators hypothesize that non-invasive brain stimulation will show a positive cumulative effect after five (5) consecutive days of stimulation on visual perception and function in adults with amblyopia.
Participants will be randomized into one of two treatment groups:
- High-frequency transcranial random noise stimulation (hf-tRNS).
- Sham stimulation.
Researchers will compare baseline measurements of crowded visual acuity, contrast sensitivity, stereoacuity, phosphene thresholds, global motion perception, form pattern recognition and pattern-reversal visual evoked potentials (VEPs) to post-treatment measurements for each group.
Being studied: Sham Transcranial Random Noise Stimulation; High Frequency Transcranial Random Noise Stimulation
Conditions: Amblyopia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults between 18 and 55 years of age
- Formal diagnosis of amblyopia in one or both eyes of any etiology
Exclusion Criteria
- History of optic nerve disease, including glaucoma and optic neuritis
- History of neurological conditions, including demyelinating disease or stroke
- Presence of metal or electronic implants in or on the body, including pacemakers
- Taking medications that can affect normal neurological function, including antipsychotics, antiepileptics, and opioids
Recruiting US locations
Midwestern University Eye Institute
Downers Grove, IL 60515
Site contact: Sherri Olsen · 630-515-7368 · solsen@midwestern.edu
Study contacts (from the official record)
- Arijit Chakraborty, PhD · 630-960-3172 · achakr@midwestern.edu
- Adrienne C Quan, OD · 630-960-3183 · aquan@midwestern.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65